INSMED INC (INSM) ROI
- 2024-06-30: ROI -66.33%.
- 2024-03-31: ROI -106.93%.
- 2023-12-31: ROI -91.03%.
- 2017-12-31: ROI -46.24%.
Complete source-backed roi history.
- Available history
- 2011-12-31 to 2024-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2024-06-30 | -66.33% |
| 2024-03-31 | -106.93% |
| 2023-12-31 | -91.03% |
| 2017-12-31 | -46.24% |
| 2016-06-30 | -48.05% |
| 2016-03-31 | -40.47% |
| 2015-12-31 | -35.09% |
| 2015-09-30 | -26.87% |
| 2015-06-30 | -23.49% |
| 2015-03-31 | -42.93% |
| 2014-09-30 | -35.12% |
| 2014-06-30 | -47.48% |
| 2014-03-31 | -32.23% |
| 2012-12-31 | -29.53% |
| 2011-12-31 | -44.44% |
Annual ROI
| Date | ROI |
|---|---|
| 2017-12-31 | -46.24% |
| 2015-12-31 | -35.09% |
| 2013-12-31 | -34.41% |
| 2012-12-31 | -29.53% |
| 2011-12-31 | -44.44% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |